Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

Medtronic's miniature leadless pacemaker, the Micra Transcatheter Pacing System (TPS), is expected to secure FDA approval during the company's 2017 fiscal year. That stretches from May 2016 through ...

Medtronic's Micra Transcatheter Pacing System (TPS) is a leadless pacemaker that is implanted into the heart using a transcatheter procedure. Micra TPS received CE Mark in April 2015 and is the ...

Medtronic plc’s MDT strength in the Cardiovascular business is poised to drive growth in the upcoming quarters. The company’s ...

Medtronic MDT has started the year 2025 on a positive note, with the stock climbing nearly 7% so far in January. This surge in market optimism follows the CMS' recent move to initiate a national ...

Medtronic plc’s MDT strength in the Cardiovascular ... The company’s next-generation Micra AV2and VR2 leadless pacemakers are particularly driving growth as they successfully enter new ...

Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...